← XTL BIOPHARMACEUTICALS LTD

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Cash and cash equivalents $2.0m $3.3m $3.3m $4.5m $3.6m $3.0m $2.1m $1.4m $371k $76k
Prepaid expenses and other current assets — — — $102k $79k $110k $85k $40k $98k $22k
Total current assets — — $8.2m $6.8m $6.1m $6.2m $3.8m $2.0m $1.3m $166k
Goodwill — — — — — — — — $3.2m —
Intangible Assets Other Than Goodwill $253k $380k $380k $380k $380k $380k $380k $380k $3.6m —
Intangible assets, net $253k $380k $380k $380k $380k $380k $380k $380k $3.8m —
Additional Financial Items
Issued Capital $6.6m $13.2m $13.2m $13.2m $13.2m $14.1m $14.1m $14.1m — —
Trade And Other Current Payables — — — — — — — — $377k —
Marketable securities – InterCure Ltd. — — $2.8m $2.3m $2.4m $3.2m $1.6m $605k $772k —
Warrants, net — — — — — — — — $1.3m $68k
Fixed assets, net — — — $2k $2k $1k — — $187k —
Warrants — — — — $2.6m $1.1m — — $689k —
Share capital - ordinary shares of NIS 0.1 par value: Authorized December 31, 2025 and 2024 - 1,450,000,000; Issued and outstanding - 946,243,356 on December 31, 2025 and 881,385,256 on December 31, 2024; — — 13.2m 13.2m 13.2m 14.1m 14.1m 14.1m 23.1m 25.1m
Reserve from transactions with non-controlling interests — — $20k $20k $20k $20k $20k $20k $20k $20k
Total Non-current assets — — — $382k $382k $381k $380k $380k $7.2m —
Total equity $2.7m $3.6m $8.3m $7.0m $6.2m $5.3m $4.0m $2.2m $5.4m ($254k)
Total Assets $3.0m $6.6m $8.6m $7.2m $6.5m $6.6m $4.2m $2.4m $5.8m $166k
LIABILITIES AND EQUITY
Accounts payable — — $253k $232k $254k $231k $187k $206k $790k $151k
Total current liabilities — — — — — — — $206k $2.2m $420k
Deferred Tax Liabilities — — — — — — — — $349k —
Total Liabilities — — — — — — — — $5.8m —
Stockholders’ equity:
Additional Paid in Capital — — — $147.7m $146.0m $146.3m $146.3m $146.3m $141.3m $140.2m
Accumulated deficit — — ($152.6m) ($153.9m) ($154.7m) ($155.1m) ($156.5m) ($158.2m) ($159.0m) ($165.6m)
Total liabilities and equity — — $8.6m $7.2m $6.5m $6.6m $4.2m $2.4m $8.6m $166k

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.